Last updated: 11 April 2019 at 7:08pm EST

Timothy J Miller Net Worth

What's Timothy Miller's mailing address?

Timothy's mailing address filed with the SEC is 1330 AVENUE OF THE AMERICAS, 33RD FLOOR, , NEW YORK, NY, 10019.

Insiders trading at Abeona Therapeutics Inc

Over the last 15 years, insiders at Abeona Therapeutics Inc have traded over 4,486,735$ worth of Abeona Therapeutics Inc stock and bought 427,809 units worth 1,765,143$ . The most active insiders traders include Capital Partners Llc Rouhan...Todd WiderMichael Amoroso. On average, Abeona Therapeutics Inc executives and independent directors trade stock every 50 days with the average trade being worth of 256,542$. The most recent stock trade was executed by Mark Alvino on 17 June 2024, trading 25,890 units of ABEO stock currently worth 116,764$.



What does Abeona Therapeutics Inc do?

abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t



What does Abeona Therapeutics Inc's logo look like?

Abeona Therapeutics Inc logo

Abeona Therapeutics Inc executives and stock owners

Abeona Therapeutics Inc executives and other stock owners filed with the SEC include: